Article in geovax

• GeoVax Presents Positive Phase 2 Trial Data for Next-Generation COVID-19 Vaccine at World Vaccine Congress

  Dr. Diamond, presented the data, emphasising GEO-CM04S1's heightened immunogenicity in immunocompromised patients. Read ahead to know more.